Several studies have explored posttreatment voice outcomes for early glottic cancer with varying results. To further clarify the voice-related quality of life (QOL) of T1 glottic cancer patients treated by external beam radiotherapy (EBRT) compared to endoscopic carbon dioxide laser excision (CLE), we performed a meta-analysis.
Methods:
We performed a meta-analysis review for the years 1966 to 2005 for the Voice Handicap Index (VHI), laryngeal cancer, voice outcome, voice quality, and quality of life. Studies in which the VHI was assessed at least 3 months after treatment for T1 glottic cancer were identified and analyzed by meta-analysis techniques.
Results:
Six studies with 208 patients (6 T1b and 202 T1a) treated with CLE and 91 patients (6 T1b and 85 T1a) treated with EBRT were identified. The posttreatment VHI scores were similar for the EBRT- and CLE-treated patients (p = .1, Wilcoxon rank sum test).
Conclusions:
We conclude that CLE and EBRT provide comparable levels of voice handicap for patients with T1 glottic cancer.
KanonierGFritschERainerTThumfartWF. Radiotherapy in early glottic carcinoma. Ann Otol Rhinol Laryngol1996;105:759–63.
2.
PellitteriPKKennedyTLVrabecDPBeilerDHellstromM. Radiotherapy. The mainstay in the treatment of early glottic carcinoma. Arch Otolaryngol Head Neck Surg1991;117: 297–301.
3.
CragleSPBrandenburgJH. Laser cordectomy or radiotherapy: Cure rates, communication, and cost. Otolaryngol Head Neck Surg1993;108:648–54.
4.
DavisRKKellySMParkinJLStevensMHJohnsonLP. Selective management of early glottic cancer. Laryngoscope1990;100:1306–9.
5.
ElnerAFexS. Carbon dioxide laser as primary treatment of glottic T1S and T1A tumours. Acta Otolaryngol Suppl (Stockh)1988(suppl 449):135–9.
6.
WedmanJHeimdalJHElstadIOlofssonJ. Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures. Eur Arch Otorhinolaryngol2002;259:547–50.
7.
SimpsonCBPostmaGNStoneREOssoffRH. Speech outcomes after laryngeal cancer management. Otolaryngol Clin North Am1997;30:189–205.
8.
LoughranSCalderNMacGregorFBCardingPMacKenzieK. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol2005;30:42–7.
9.
RydellRSchalenLFexSElnerA. Voice evaluation before and after laser excision vs. radiotherapy of T1A glottic carcinoma. Acta Otolaryngol (Stockh)1995;115:560–5.
10.
McGuirtWFBlalockDKoufmanJA. Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch Otolaryngol Head Neck Surg1994;120:951–5.
11.
RovirosaAMartinez-CeldranEOrtegaA. Acoustic analysis after radiotherapy in T1 vocal cord carcinoma: A new approach to the analysis of voice quality. Int J Radiat Oncol Biol Phys2000;47:73–9.
12.
WoodsonGERosenCAMurryT. Assessing vocal function after chemoradiation for advanced laryngeal carcinoma. Arch Otolaryngol Head Neck Surg1996;122:858–64.
13.
LehmanJJBlessDMBrandenburgJH. An objective assessment of voice production after radiation therapy for stage I squamous cell carcinoma of the glottis. Otolaryngol Head Neck Surg1988;98:121–9.
14.
JacobsonBHJohnsonAGrywalskiCSilbergleitAJacobsonGBenningerMS. The Voice Handicap Index (VHI): Development and validation. Am J Speech Lang Pathol1997;6: 66–70.
15.
PerettiGPiazzaCBalzanelliCMensiMCRossiniMAntonelliAR. Preoperative and postoperative voice in Tis-T1 glottic cancer treated by endoscopic cordectomy: An additional issue for patient counseling. Ann Otol Rhinol Laryngol2003;112:759–63.
16.
RothmanKJGreenlandS. Modern epidemiology. 2nd ed.Philadelphia, Pa: Lippincott-Raven, 1998:660–1.
17.
BrondboKBenningerMS. Laser resection of T1a glottic carcinomas: Results and postoperative voice quality. Acta Otolaryngol (Stockh)2004;124:976–9.
18.
PeetersAJvan GoghCDGoorKMLeeuwIM Verdonck-DeLangendijkJAMahieuHF. Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol2004;261:534–40.
19.
BehrmanAAbramsonALMyssiorekD. A comparison of radiation-induced and presbylaryngeal dysphonia. Otolaryngol Head Neck Surg2001;125:193–200.
20.
FungKYooJLeeperHA. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck. Laryngoscope2001;111:1920–4.
21.
CohenSMDupontWDCoureyMS. Quality-of-life impact of non-neoplastic voice disorders: A meta-analysis. Ann Otol Rhinol Laryngol2006;115:128–34.
22.
JohnsMMGarrettCGHwangJOssoffRHCoureyMS. Quality-of-life outcomes following laryngeal endoscopic surgery for non-neoplastic vocal fold lesions. Ann Otol Rhinol Laryngol2004;113:597–601.
23.
SpectorBCNettervilleJLBillanteCClaryJReinischLSmithTL. Quality-of-life assessment in patients with unilateral vocal cord paralysis. Otolaryngol Head Neck Surg2001;125:176–82.
24.
BenningerMSGardnerGGrywalskiC. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia. Arch Otolaryngol Head Neck Surg2001;127:1083–5.
25.
RosierJFGregoireVCounoyH. Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: A retrospective evaluation. Radiother Oncol1998;48:175–83.
26.
UrkenMLBillerHF. Management of early vocal cord carcinoma. Oncology1988;2:48–62.
27.
BenningerMSGillenJThiemePJacobsonBDragovichJ. Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope1994;104:294–8.
28.
ZeitelsSMHillmanREFrancoRABuntingGW. Voice and treatment outcome from phonosurgical management of early glottic cancer. Ann Otol Rhinol Laryngol Suppl2002;111(suppl 190).
